Vertex Pharmaceuticals Inc (NASDAQ:VRTX)
| 225.50 Delayed Data As of 4:00pm ET |  -12.45 / -5.23%Today’s Change | 163.68 Today|||52-Week Range 249.85 | +2.99% Year-to-Date |
Stock Price Forecast
The 23 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 270.00, with a high estimate of 300.00 and a low estimate of 224.00. The median estimate represents a +19.73% increase from the last price of 225.50.
Analyst Recommendations
The current consensus among 27 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
$1.78
$1.78
Sales
$1.3B
$1.3B
Reporting Date
Apr 23
Apr 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly 4.94%
Growthannually 44.69%
Sales
Growthquarterly 0.27%
Growthannually 32.71%
